Iradimed promotes Chris Scott to CFO and COO with new employment agreement

IRADIMED CORP

Chris Scott appointed Chief Financial and Operating Officer effective July 8, 2021.
Base salary of $360,000/year; annual bonus target 60% of salary.
Immediate RSU grant of $150,000 vesting over four years.
Annual equity target of $400,000 under incentive plan.
Severance: 12 months base salary for without cause/good reason; 18 months for change in control.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Chris Scott

Chief Financial and Operating Officer

IRMD · IRADIMED CORP

Effective: 2021-07-08
Filed: July 12, 2021, 7:59 PM ET

On July 8, 2021, Iradimed Corporation (the “Company”) appointed Chris Scott, 51, as its Chief Financial and Operating Officer effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chris Scott was appointed as Chief Financial and Operating Officer at IRADIMED CORP.

Action: appointed
Role: Chief Financial and Operating Officer

Exact text from the filing

On July 8, 2021, Iradimed Corporation (the “Company”) appointed Chris Scott, 51, as its Chief Financial and Operating Officer effective immediately.

View on SEC.gov

IRADIMED CORP filing history →

Source: SEC EDGAR

accession 0000898432-21-000566

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.